[慢性阻塞性肺病 (COPD):埃索诺菲利亚和新药疗法]
L Biener1, C Pizarro2, D Skowasch2
1Medizinische Klinik und Poliklinik II - Kardiologe, Pneumologie, Angiologie, Universitätsklinikum Bonn, Venusberg Campus 1, 53127, Bonn, Deutschland. leonie.biener@ukbonn.de.
Innere Medizin (Heidelberg, Germany)
|June 3, 2024
概括
慢性阻塞性肺病 (COPD) 的个性化治疗正在取得进展. 建议在COPD患者中吸入三重疗法,这些患者具有高的乙氨基酸细胞计数,特别是那些经历了恶化的人.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 的表型确定对于开发个性化治疗策略至关重要.
- 了解COPD异质性是优化患者护理的关键.
研究的目的:
- 审查COPD的不同表型.
- 总结当前的药物治疗概念,重点关注埃索诺菲尔呼吸道炎症.
主要方法:
- 对前性,随机,安慰剂对照研究的分析.
- 吸入三重治疗 (吸入皮质类固醇和双重支气管扩张) 的评估.
- 评估生物疗法 (dupilumab) 对于eosinophilic COPD的治疗方法.
主要成果:
- 吸入的三重疗法可以减少COPD患者的恶化和死亡率,特别是那些血液中异氨基细胞数量较高的患者.
- 杜皮卢马布已显示出有效的降低COPD与eosinophilia的恶化.
- 乙氨基酸水平指导这些疗法的有效性.
结论:
- 双支支气管扩张是COPD的基础,没有恶化.
- 吸入三重疗法适用于COPD恶化,血中乙氨基酸计数≥300/μl,并可能有利于计数在100-300/μl之间的患者.
- 杜皮卢马布代表了对欧诺菲尔性COPD表型的潜在未来治疗方法.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
271
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
271
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
Drugs Used in Lower Respiratory Disorders: Overview
420
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
420
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


